Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer

"Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer." Acta Oncologica, 53(3), pp. 427–428

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.